Antibiogram Machine Susceptibility and evidence explorer
Period B · Floor / Urine11 of 12 cells displayed at n ≥ 30. Counts remain available when an estimate is suppressed.
Organism ↓
Antibiotic →
Antibiotic →
Ceftriaxone
Cefepime
Ciprofloxacin
Piperacillin/tazobactam
E. coli
K. pneumoniae
P. aeruginosa
0%50%100%
Suppressed or missing—read cell text Selected cell
Open the accessible data table
| Organism | Ceftriaxone | Cefepime | Ciprofloxacin | Piperacillin/tazobactam |
|---|---|---|---|---|
| E. coli | 85%, 120 tested | 93%, 115 tested | 70%, 120 tested | 92%, 110 tested |
| K. pneumoniae | 67%, 64 tested | 85%, 60 tested | 64%, 64 tested | 83%, 58 tested |
| P. aeruginosa | NOT REPORTED | 76%, 38 tested | 63%, 32 tested | 79%, 38 tested |
THREE GUIDED DISCOVERIES
90% does not describe the evidence width.
18 / 20 = 90%95% Wilson interval 69.9–97.2%
90 / 100 = 90%95% Wilson interval 82.6–94.5%
Equal percentages can carry different sampling uncertainty. More observations narrow this interval; they do not remove bias.
SYNCHRONIZED EXPORT
Period B · Floor / Urine · threshold 30The CSV uses the same suppression status shown above.Method, calculation boundaries, and reference
These are deterministic teaching fixtures. Comparisons subtract unrounded proportions and round once for display. S + I + R equals the antibiotic-specific tested count. Tested counts are never added across antibiotics to infer patients. Suppressed, missing, and actual 0% results remain distinct.
Real antibiograms require laboratory-verified results, isolate de-duplication, current breakpoints, and consistent reporting. See CLSI M39 ↗. This demonstration does not claim M39 compliance.
Educational software only. Not for diagnosis, treatment selection, dosing, or patient care.